baber/WOPTO huggingface dataset:
Patent AU-4520300-A (AU)
Title: Echo and distortion cancellation arrangement
Inventor: RANDAHL TORBJORN
IPC: H04B3/20
Filed: 1999-12-17
Abstract: At the output of a line driver (1) connected to a long transmission line, signals received on the transmission line are only a fraction of signals transmitted by the line driver on the transmission line. To minimize the transmitted signal with its distortion and noise in the receive path of the line driver, an additional driver (4) having the same voltages and currents in the signal path, is added. The additional driver (4) drives an additional load (Z2). The signal transmitted to the transmission line together with its superimposed received signal, is subtracted from the signal from the additional driver (4), which is not superimposed on any received signal. The resulting signal is reduced from transmitted signal, transmitted distortion and transmitted noise. To minimize die size and power consumption, the additional driver (4) is scaled, but the distortion remains unchanged compared to the "normal" line driver.
Patent AU-4811400-A (AU)
Title: Competitive chemiluminescent assay for cyclic nucleotide monophosphates
Inventor: BRONSTEIN IRENA Y
IPC: G01N33/53
Filed: 2000-05-02
Abstract: A competitive assay for the concentration of a cyclic nucleotide such as cyclic adenosine monophosphate combines, in a reaction chamber provided with a capture antibody, an antibody for the cAMP or other cyclic nucleotide, the sample to be assayed and a conjugate of cAMP and alkaline phosphatase. The mixture is incubated and washed, and after washing, a 1,2-dioxetane which is caused to decompose when contacted by the alkaline phosphatase of said conjugate is added. The light emission caused by decomposition is measured, with the strength of the signal being inversely related to the concentration of the cyclic nucleotide. Optionally, an enhancement agent in the form of a polymeric onium salt may be added, to further enhance the light emission.
Patent AU-4857801-A (AU)
Title: Phenotyping assay and reagents therefor
Inventor: KLEIM JOERG-PETER
IPC: C12Q1/68
Filed: 2001-04-12
Abstract: The present invention relates to methods for generating recombinant viruses from samples such as uncharacterised virus samples or clinical specimens and to the use of the viruses so generated in assays, predominantly for the purpose of detecting altered viral susceptibility to anti-viral drugs and reagents. The invention further relates to deoxyribonucleic acid (DNA) sequences applied in the new methods and assays. The methods and assays are adapted to detect resistant virus more rapidly, sensitively and accurately than known assays by taking into account additional compensatory mutations arising in nucleotide sequences other than those encoding the anti-viral drug target, and by requiring fewer recombination events to generate recombinant virus.
Patent AU-4870385-A (AU)
Title: Novel production processes
Inventor: MARTIN PIERRE
IPC: C07C49/255
Filed: 1985-10-15
Abstract: There is described a process for producing fungicidally active 4-phenylpyrrole derivatives of the formula I    <IMAGE>  (I)  wherein R is halogen, C1-C6-alkyl or C1-C6-haloalkyl, and n is 0, 1 or 2, which process comprises reacting a 3-trifluoromethyl-4-phenylpyrrole of the formula II    <IMAGE> (II)  wherein Rn is as defined under the formula I, and R1 is hydrogen or an acyl group, at elevated temperature and elevated pressure, with ammonia. Important intermediates and the production thereof are also described.
Patent AU-5208101-A (AU)
Title: Cxcr4 agonist treatment of hematopoietic cells
Inventor: SALARI HASSAN
IPC: A61K45/00
Filed: 2001-04-12
Abstract: In accordance with various aspects of the invention, CXCR4 agonists, including SDF-1 polypeptides and SDF-1 polypeptide homologues, may be used in reducing the rate of hematopoietic cell multiplication. Methods of the invention may comprise administration of an effective amount of an CXCR4 agonist to cells selected from the group consisting of hematopoietic stem cells and hematopoietic progenitor cells. Cells may be treated in vitro or in vivo in a patient. A therapeutically effective amount of the CXCR4 agonist may be administered to a patient in need of such treatment. Patients in need of such treatments may include, for example patients requiring bone marrow or peripheral blood stem cell transplantation.
Patent AU-5229396-A (AU)
Title: New heterocyclic spiro compounds, process for the preparation thereof,and pharmaceutical compositions containing them
Inventor: CHARTON YVES
IPC: C07D498/10
Filed: 1996-05-15
Abstract: 8-(Hetero)arylmethoxyphenylalk(ano)yl-8-azaspiro(4,5) decane derivs. of formula (I) and their enantiomers, diastereoisomers and salts are new. In (I), Ar = mono- or bicyclic aromatic hydrocarbyl (opt. substd. by halo, alkyl, alkoxy, CF3 or phenyl) or mono- or bicyclic heterocyclyl contg. 1-3 O, N or S and opt. substd. as above; R = H or OH; R' = H; or alkyl, phenyl, phenylalkyl, cycloalkyl or cycloalkylalkyl (all opt. substd. by halo, alkyl, alkoxy or CF3) or CRR'=CO; A = direct bond, CO or 1-5C n-hydrocarbylene opt. contg. O and/or substd. by 1 or 2 of halo, alkyl, alkoxy and oxo; Het = 5-membered heterocycle contg. 1-4 O, N or S and opt. substd. by 1 or 2 of alkyl, alkoxy, OH, O, SH, S, aminoalkyl, alkylaminoalkyl and dialkylaminoalkyl; alkyl moieties have 1-5 C atoms and cycloalkyl moieties 3-8 C atoms.
Patent AU-5237299-A (AU)
Title: Alternative electrode supports and gas distributors for molten carbonate fuel cell applications
Inventor: HILL ANDY H
IPC: H01M8/02
Filed: 1999-07-28
Abstract: A molten carbonate fuel cell having an anode electrode, a cathode electrode, and an electrolyte matrix disposed between the anode electrode and the cathode electrode. An electrode support constructed of a high porosity reticulated foam material is disposed on an anode electrode face of at least one of the anode electrode and the cathode electrode facing away from the electrolyte matrix and forming a plurality of pores. An electrolyte is disposed within at least a portion of the plurality of pores, whereby at least a portion of the electrolyte flows into the electrolyte matrix during initial conditioning of the fuel cell.
Patent AU-5516694-A (AU)
Title: Surgical implant & surgical kit
Inventor: TORRIE PAUL ALEXANDER
IPC: A61B17/58
Filed: 1994-02-15
Abstract: Surgical kits for the implantation of soft tissue-to-bone anchors and expandable, preferably bioabsorbable, soft tissue anchors. The surgical kits include an embodiment with an outer tube with an expandable anchor releasably attached to its distal end, for guiding the anchor into a predrilled hole; an inner tube with an anchor expanding pin sized for expanding the anchor releasably held in its bore; and a pushrod for pushing the anchor pin into the anchor to expand it and wedge it in a hole. In an alternative embodiment, the anchor pin is attached to the distal end of a pushrod inserted into an outer tube. In one embodiment, the anchor is equipped with downward extending spikes on the underside of an enlarged head for gripping soft tissue and bending barbs to resist withdrawal of the anchor from bone. In another embodiment, the anchor's proximal end has no enlarged head but is equipped with sutures. In a further embodiment, the anchor's enlarged head is tilted at an angle to allow better engagement of spikes with soft tissue. <IMAGE>
Patent AU-5722486-A (AU)
Title: Compositions for the preparation of microparticles permitting a prolonged release of a biologically active substance
Inventor: DROUIN JEHAN-YVES
IPC: A61K9/22
Filed: 1986-05-07
Abstract: 1. A composition for the preparation by extrusion of microparticles permitting a prolonged release of a biologically active substance, which composition consists of a biologically active substance, one or more non-hydrophilic polymers and from 10 to 40% by weight either of a mixture of at least two lipid excipients one of which has the property of dissolving or gelling the polymer or polymers and the other has lubricating properties or of a lipid excipient having both the property of dissolving or gelling the polymer or polymers and lubricating properties, and, if appropriate, one or more additives chosen from diluents and antistatic agents.
Patent AU-5741494-A (AU)
Title: Glaucoma treatment
Inventor: LIPTON STUART A
IPC: A61K31/13
Filed: 1993-12-06
Abstract: Elevated glutamate levels are associated with glaucoma, and damage to retinal ganglion cells can be controlled by administering to the patient a compound capable of reducing glutamate induced excitotoxicity in a concentration effective to cause reduction of such excitotoxicity.
Patent AU-5821400-A (AU)
Title: Diagnosis of gluten sensitive enteropathy and other autoimmunopathies
Inventor: PAULSSON MATS
IPC: G01N33/573
Filed: 2000-06-28
Abstract: Method for diagnosis of autoimmune diseases of the GSE-type or associated with gluten sensitive enteropathy comprising taking a sample and testing the sample for antibodies against human tissue transglutaminase, tissue-specific transglutaminases, or other transglutaminases. It was found that autoimmune diseases other than celiac disease can be diagnosed and distinguished in this way, notably, dermatitis herpetiformis Duhring, Crohn's disease, Addison's disease, AI hemolytic anemia, AI thrombocytopenic purpura, AI thyroid diseases, atrophic gastritis—pernicious anemia, IgA nephropathy or IgA glomerulonephritis, myasthenia gravis, partial lipodystrophy, polymyositis, primary biliary cirrhosis, primary sclerosing cholangitis, recurrent pericarditis, relapsing polychondritis, rheumatoid arthritis, rheumatism, sarcoidosis, Sjögren's syndrome, SLE, splenic atrophy, type I (insulin-dependent) diabetes mellitus, diabetes mellitus of other types, ulcerative colitis, vasculitis (both systemic and cutaneous), vitiligo as well as autoimmune diseases associated with infertility, increased risk of abortion, or reduced fetal growth.
Patent AU-5825780-A (AU)
Title: Electrically stunning animals
Inventor: NIJHUIS J W
IPC: A22B3/06
Filed: 1980-05-09
Abstract: The invention relates to an apparatus for electrically stunning animals, said apparatus comprising two endless conveyors (1,2) running parallel to each other and positioned to form a V-shaped passage way therebetween as well as two sets of electrodes (3,4) which extend downwardly into the V-shaped passage way and can swing about horizontal axis (5,7) located above the passage way, of which electrodes (3,4) seen in the direction of movement of the conveyors, the first set (3) slopes downwardly and forwardly and have a short electrode surface (13) only at the bottom end, whilst the second set (4) slopes downwardly and backwards, said electrodes carrying electrode surfaces (15) over substantially the entire side that faces the first set (3).
Patent AU-5951396-A (AU)
Title: Preparation of an acylated protein powder
Inventor: BAKER JEFFREY CLAYTON
IPC: C07K1/30
Filed: 1996-06-04
Abstract: A method for recovering an acylated protein as a powder, especially in cases where said acylated protein is one that resists isolation by isoelectric precipitation from aqueous solutions of the protein, said method comprising in combination adjusting said aqueous solution to near the isoelectric pH of the protein and providing a suitable alcohol concentration to cause precipitation of the protein in the form of filterable particles at said pH.
Patent AU-5972580-A (AU)
Title: Stilbene derivatives useful as optical brighteners
Inventor: ECKES H
IPC: C07D413/10
Filed: 1980-06-27
Abstract: Triazolyl stilbene compounds of the formula   <IMAGE>   wherein A is a benzene or naphthalene ring optionally substituted by non-chromophoric substituents and B is a substituted 1,2,4-oxdiazole (3) or 1,3,5-oxdiazole (2) group, as well as a procedure for their manufacture and their use as optical brighteners.
Patent AU-6187601-A (AU)
Title: Optical transmission system
Inventor: CAVALIERE FABIO
IPC: H04B10/296
Filed: 2001-08-17
Abstract: Data transmitted on optical fibre over long distances is subject to the introduction of errors at the receiving end, caused by distortions and alterations of the original data. Raising the transmission power to increase the level of signals at the receiving end also increases errors due to non-linear characteristics of the fibre. The invention optimises launch power by assessing error rates due to amplified spontaneous emissions and due to four wave mixing, so that signal to noise ratios due to these causes exceed threshold levels whilst enabling launch power to be maximised. <IMAGE>
Patent AU-6255796-A (AU)
Title: Mutant alpha-amylase
Inventor: MITCHINSON COLIN
IPC: C12N1/21
Filed: 1996-06-06
Abstract: Novel  alpha -amylase enzymes are disclosed in which one or more asparagine residues are substituted with a different amino acid or deleted. The disclosed  alpha -amylase enzymes show altered or improved low pH starch hydrolysis performance, stability and activity profiles.
Patent AU-6293500-A (AU)
Title: Antenna for contactless cards, hybrid cards and electronic labels
Inventor: MARTIN DAVID
IPC: H01Q7/00
Filed: 2000-07-05
Abstract: The invention concerns an antenna for integrated circuit contactless cards, integrated circuit hybrid cards and/or electronic labels, characterised in that the antenna track (10) is longitudinally divided into sub-tracks (11, 12). The invention is applicable to integrated circuit contactless cards, integrated circuit hybrid cards and electronic labels.
Patent AU-6323700-A (AU)
Title: Package, comprising a series of individual product packages
Inventor: GURP PAULUS MARIA VAN
IPC: B65D71/00
Filed: 2000-07-28
Abstract: A package (1) comprising a series of individual product packages (2), the package (1) comprising a tubular wrapper (6), open at at least one and preferably both ends, which wrapper (6) abuts against the outside of the product packages (2), while on the inside of the wrapper (6), at least adjacent the ends, friction increasing means are provided.
Patent AU-6324298-A (AU)
Title: Dinucleotides and their use
Inventor: PENDERGAST WILLIAM
IPC: C07H19/10
Filed: 1998-02-06
Abstract: The present invention relates to certain novel dinucleotides and formulations thereof which are highly selective agonists of the P2Y<SUB>2 </SUB>and/or P2Y<SUB>4 </SUB>purinergic receptor. They are useful in the treatment of chronic obstructive pulmonary diseases such as chronic bronchitis, PCD, cystic fibrosis, as well as prevention of pneumonia due to immobility. Furthermore, because of their general ability to clear retained mucus secretions and stimulate ciliary beat frequency, the compounds of the present invention are also useful in the treatment of sinusitis, otitis media and nasolacrimal duct obstruction. They are also useful for treatment of dry eye disease and retinal detachment as well as facilitating sputum induction and expectoration.
Patent AU-6539499-A (AU)
Title: Meniscal repair device
Inventor: SCHWARTZ HERBERT E
IPC: A61B17/56
Filed: 1999-12-22
Abstract: A device for repairing a soft tissue defect, particularly a defect in the meniscus of a knee, comprises an outer wall anchor for engaging against an outside wall of the meniscus on a first side of the defect, and an inner meniscal anchor engaging an inner surface of the meniscus on a second side of the defect. The inner meniscal anchor has a locking mechanism, and a suture adjustably connecting the outer wall anchor to the inner meniscal anchor. Tension on the suture pulls the defect together and the locking mechanism then locks the suture in place. <IMAGE>
Patent AU-6675694-A (AU)
Title: Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
Inventor: KRUGER MARTIN
IPC: C07D471/06
Filed: 1994-04-28
Abstract: PCT No. PCT/DE94/00494 Sec. 371 Date Dec. 27, 1995 Sec. 102(e) Date Dec. 27, 1995 PCT Filed Apr. 28, 1994 PCT Pub. No. WO94/25472 PCT Pub. Date Nov. 10, 1994Pyrido[1,2,3-de]quinoxaline derivatives of formula I    <IMAGE>  (I)  in which R1, R2 and R3 each mean hydrogen, -POXY, halogen or -COR, R4 means hydrogen or OH, R5, R6 and R7 are the same or different and mean hydrogen, halogen, nitro, NR12R13, cyano, CF3, C1-6 alkyl, C1-4 alkoxy, or R5 and R6 or R6 and R7 represent a fused benzene ring, and means a single or double bond, are described as well as their production and use in pharmaceutical agents.
Patent AU-6730600-A (AU)
Title: Vitamin d derivatives having substituents at the 2alpha-position
Inventor: TAKAYAMA HIROAKI
IPC: A61P3/14
Filed: 2000-08-25
Abstract: An object of the present invention is to synthesize a novel vitamin D3 derivative having a substituent at the 2 alpha -position. The present invention provides vitamin D derivatives represented by Formula (I): <CHEM>  wherein   R<1> represents a saturated aliphatic C1-15hydrocarbon group optionally substituted with 1 to 3 hydroxy or protected hydroxy groups; and R<2> represents a saturated aliphatic C1-10hydrocarbon group optionally substituted with one or more substituents, which may be the same or different and which are selected from the group consisting of a hydroxy group, a halogen atom, a cyano group, a lower alkoxy group, an amino group and an acylamino group, provided that when R<2> represents a saturated aliphatic C1hydrocarbon group, R<2> is substituted with at least one substituent.
Patent AU-6819800-A (AU)
Title: A method and an apparatus for stimulating/modulating biochemical processes using pulsed electromagnetic fields
Inventor: DISSING STEEN
IPC: A61N2/02
Filed: 2000-08-28
Abstract: A method for stimulating growth in biological tissue or sprouts, an apparatus and a use thereof. The apparatus comprises of a pulse generator and a plurality of coils in which pulsed currents will cause fluctuating magnetic fields in a predetermined region holding the material to be stimulated. The fluctuating magnetic fields will induce an electric field in the material. An enhanced effect has been detected in the regions where the electric fields are largest. The coils comprise a number of pairs of coils having, during a given pulse, magnetic fields in opposite directions in order to provide field gradients in the cells, micro organisms or tissue. Selecting a suitable number, size and positioning of coils will provide a homogeneous electric field in the predetermined region, which does not have any undesirable peaked maxima. When four or more coils are used, they can be combined in pairs arranged on opposite sides of the predetermined region, and with the adjacent coils conducting current in opposite directions and the opposing coils conducting currents in the same direction. Thereby the induced electridal fields add constructively inside the regions between the pairs of coils. In an apparatus for stimulating cell proliferation and differentiation, it is a desired feature that the generated fluctuations in the magnetic fields does not elicit action potentials of living cells since this will cause great inconvenience for the patient.
Patent AU-7012896-A (AU)
Title: Vegf-related protein
Inventor: LEE JAMES
IPC: A61P9/00
Filed: 1996-08-30
Abstract: A human VEGF-related protein (VRP) has been identified and isolated that binds to, and stimulates the phosphorylation of, the receptor tyrosine kinase Flt4. The VRP is postulated to be a third member of the VEGF protein family. Also provided are antibodies that bind to VRP and neutralize a biological activity of VRP, compositions containing the VRP or antibody, methods of use, chimeric polypeptides, and a signal polypeptide for VRP. <IMAGE>
Patent AU-7052201-A (AU)
Title: Tyre comprising a reinforcing profiled section in at least one sidewall, and mounted tyre/rim assembly
Inventor: DRIEUX JEAN-JACQUES
IPC: B60C3/06
Filed: 2001-05-14
Abstract: A tire having a radial carcass reinforcement winding within each bead around at least one heel reinforcement element and whose meridian profile, when the tire is mounted and inflated, has a constant direction of curvature in a first bead and a sidewall extending it radially, and has a tangent TT' to the point of tangency T of the carcass reinforcement profile with the annular element of the first bead which forms with the axis of rotation an angle phi which is open towards the outside and is greater than 45°, wherein, viewed in meridian section, at least the aforesaid sidewall comprises a reinforcing profiled element having, viewed in section, substantially the form of a crescent, one of the axially inner or outer faces of the crescent-shaped profiled element follows the profile of the carcass reinforcement, and the trace of the face of the crescent-shaped profiled element opposite the face of such profiled element closest to the carcass reinforcement has a single direction of curvature.
Patent AU-7068591-A (AU)
Title: Ventilatory instrument for measuring peak expiratory flow
Inventor: STOCKWELL JAMES ALFRED
IPC: A61B5/08
Filed: 1991-01-21
Abstract: PCT No. PCT/EP91/00124 Sec. 371 Date Jul. 30, 1992 Sec. 102(e) Date Jul. 30, 1992 PCT Filed Jan. 21, 1991 PCT Pub. No. WO91/11140 PCT Pub. Date Aug. 8, 1991.A peak flow meter has a flexible resilient vane which is rigidly mounted by one end and which has its other end engaged with a slider indicator which slides in a slot formed in a curved wall of the casing. In use, the human subject blows into the casing through a mouthpiece. The vane is bent by the expiration which vents through the part of the slot between the slider and the mouthpiece. The slider stops at the furthest point from the mouthpiece to which it is moved by the vane and that point is an indication of the peak expiratory flow of the human subject.
Patent AU-7297587-A (AU)
Title: Machine for the extrusion of several materials at the same time
Inventor: FIGUEREO BLAISE FRANCOIS
IPC: B29C48/49
Filed: 1987-05-15
Abstract: A machine is especially adapted for coating a profile insert and can be distinguished by the fact that it consists of several extruder screws (1, 2, 3) incorporated into a single block (4), each fed from a hopper opening, through a corresponding orifice (1', 2', 3'), into a union head (5) having a channel (6, 7, 8) for each material being extruded and hollowed out axially for an insert to pass through, this union head (5) feeding, via a distributor ring (9) perforated and grooved concentrically according to the channels in this head, an extrusion chamber (10) with controlled streams, carrying at its exit an extrusion head (11) with a reserved passage for the insert, the head consisting of a frustoconical liner (12) housing, between its entry and its exit, an externally ribbed diffuser (13), in which each groove between two ribs corresponds to an orifice of the extrusion chamber (10), an externally ribbed and grooved frustoconical core (13a) such that its ribs and grooves corresponds to those of the diffuser (13), a die (13b) hollowed out internally with conicity corresponding to the conicity of the radial ribs and grooves of the core (13a), this die comprising a passage cut out to the shape of the desired profile.
Patent AU-7392901-A (AU)
Title: Cosmetic agent in the form of a gel
Inventor: BIRKEL SUSANNE
IPC: A61K8/04
Filed: 2001-04-07
Abstract: A cosmetic preparation in gel form is described which contains undissolved, water-swollen polymer particles and at the interface with gaseous substances forms reversibly a grainy, uneven, light-scattering surface and at the interface with solids forms reversibly a smooth, level, non-light-scattering surface. Preferred gel formers are superabsorbing polymers. A preferred use is the hair-end protection in permanent wave treatment.
Patent AU-7423894-A (AU)
Title: A container for blood
Inventor: FINI MASSIMO
IPC: A61M1/36
Filed: 1994-09-26
Abstract: The container (1) comprises a generally rigid support (6) which, in combination with a filter element such as a net (9), defines a blood-inlet chamber of substantially constant size and geometrical shape. An expandible holding portion (7) is associated with the support (6) and, preferably, has a bellows-like configuration. <IMAGE>